In vivo gene editing works in humans: Results of a phase 1 clinical trial for TTR amyloidosis

Mol Ther. 2021 Sep 1;29(9):2633-2634. doi: 10.1016/j.ymthe.2021.08.014. Epub 2021 Aug 24.
No abstract available

Publication types

  • Comment

MeSH terms

  • Amyloidosis*
  • Gene Editing*
  • Genetic Therapy
  • Humans
  • Prealbumin / genetics

Substances

  • Prealbumin